Canopy Growth (CGC) stock price, revenue, and financials

Canopy Growth market cap is $7.8 b, and annual revenue was C$226.34 m in FY 2019

$7.8 B

CGC Mkt cap, 20-Feb-2020

C$123.8 M

Canopy Growth Revenue Q3, 2020
Canopy Growth Gross profit (Q3, 2020)60.2 M
Canopy Growth Gross profit margin (Q3, 2020), %48.7%
Canopy Growth Net income (Q3, 2020)-124.2 M
Canopy Growth EBIT (Q3, 2020)-171.5 M
Canopy Growth Cash, 31-Dec-20191.6 B
Canopy Growth EV6.8 B

Canopy Growth Revenue

Canopy Growth revenue was C$226.34 m in FY, 2019 which is a 190.4% year over year increase from the previous period.

Embed Graph

Canopy Growth Revenue Breakdown

Embed Graph

Canopy Growth revenue breakdown by business segment: 27.1% from Medical Revenue (Canadian), 46.3% from Recreational Revenue (Business to Business), 13.4% from Other Revenue, 9.1% from Recreational Revenue (Business to Consumer) and 4.0% from Other

Canopy Growth Income Statement

Annual

CADFY, 2017FY, 2018FY, 2019

Revenue

39.9m77.9m226.3m

Revenue growth, %

95%190%

Cost of goods sold

1.2m3.8m137.4m

Gross profit

38.7m74.2m88.9m

Gross profit Margin, %

97%95%39%

Sales and marketing expense

13.0m38.2m154.4m

R&D expense

810.0k1.5m15.2m

General and administrative expense

16.9m43.8m168.4m

Operating expense total

52.8m156.5m666.0m

Depreciation and amortization

6.1m20.5m21.5m

EBIT

(14.1m)(82.3m)(577.0m)

EBIT margin, %

(35%)(106%)(255%)

Interest expense

2.0m

Interest income

49.3m

Pre tax profit

(10.3m)(52.5m)(657.8m)

Income tax expense

(2.7m)1.6m12.3m

Net Income

(7.6m)(54.1m)(670.1m)

Canopy Growth Balance Sheet

Annual

CADFY, 2017FY, 2018FY, 2019

Cash

101.8m322.6m2.5b

Accounts Receivable

2.8m5.9m61.8m

Prepaid Expenses

7.4m35.3m

Inventories

46.0m101.6m262.1m

Current Assets

178.8m481.8m5.1b

PP&E

96.3m303.7m1.1b

Goodwill

241.4m314.9m1.5b

Total Assets

702.7m1.4b8.7b

Accounts Payable

46.2m188.9m

Short-term debt

1.7m1.6m106.7m

Current Liabilities

17.7m92.0m411.7m

Long-term debt

8.6m6.9m842.3m

Total Debt

10.3m8.4m949.0m

Total Liabilities

63.0m193.6m1.5b

Common Stock

621.5m1.1b6.0b

Retained Earnings

(21.3m)(91.6m)(777.1m)

Total Equity

639.7m1.2b7.2b

EPS

(0.1)(0.4)(2.6)

Debt to Equity Ratio

0 x0 x0.1 x

Debt to Assets Ratio

0 x0 x0.1 x

Financial Leverage

1.1 x1.2 x1.2 x

Canopy Growth Cash Flow

Annual

CADFY, 2017FY, 2018FY, 2019

Net Income

(7.6m)(54.1m)(670.1m)

Depreciation and Amortization

6.1m20.5m46.9m

Accounts Receivable

(2.2m)(15.7m)(67.7m)

Inventories

(24.5m)(176.9m)

Accounts Payable

(200.0k)27.1m69.5m

Cash From Operating Activities

(27.1m)(81.5m)(520.5m)

Purchases of PP&E

(29.4m)(176.0m)(644.5m)

Cash From Investing Activities

(18.6m)(223.6m)(3.2b)

Long-term Borrowings

(959.0k)(1.5m)(35.6m)

Cash From Financing Activities

132.1m525.8m5.8b

Net Change in Cash

86.4m220.8m2.2b

Canopy Growth Ratios

CADY, 2019

EV/EBIT

-39.5 x

EV/CFO

-12.4 x

Revenue/Employee

25.3k

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.5 x

Canopy Growth Operating Metrics

FY, 2017Q1, 2018Q2, 2018Nov, 2017Q3, 2018Feb, 2018Q4, 2018FY, 2018Q1, 2019Aug, 2018Q2, 2019Nov, 2018Q3, 2019Feb, 2019Q4, 2019FY, 2019Jun, 2019Q1, 2020Aug, 2019Q2, 2020Q3, 2020

Cannabis Sold, kilogram and kilogram equivalents

5.14 k1.83 k2.02 k2.33 k2.53 k8.71 k2.70 k2.20 k10.10 k9.33 k24.32 k10.55 k10.91 k13.24 k

Cannabis Harvested, kilograms

10.84 k5.58 k4.17 k7.96 k4.81 k22.51 k9.69 k15.27 k7.56 k14.47 k46.93 k40.96 k40.57 k29.92 k

Patients (Spectrum Therapeutics, Canada)

55 k59 k63 k69 k74 k82 k83.40 k73.60 k70.90 k75.60 k76.75 k

Average Selling Price per Gram

C$7 C$7 C$7 C$8 C$8 C$8 C$8 C$9 C$7 C$7 C$7 C$7 C$7 C$7

Average Selling Price per Gram (Recreational)

C$6 C$7 C$7 C$6 C$5 C$5

Average Selling Price per Gram (Canadian Medical)

C$8 C$8 C$8 C$8 C$8 C$8 C$8 C$8 C$7

Average Selling Price per Gram (International Medical)

C$13 C$13 C$13 C$13 C$13 C$13 C$61 C$43 C$49

Retail Stores, Tweed and Tokyo Smoke

11 15 23 26 26 27 28

Corporate-Owned Stores, Tweed and Tokyo Smoke

19 21 21 22 22

Corporate-Owned Stores, Tokyo Smoke

4 5 5 6 6

Corporate-Owned Stores, Tweed

15 16 16 16 16

Patents Issued

32 90 111 111 130 130

Patent Applications

140 230 270 270 300 350

Patent Applications (US)

27 27 39 39 43 38 38 94

Brands

14 19 21

Canopy Growth Employee Rating

4.069 votes
Culture & Values
4.0
Work/Life Balance
3.7
Senior Management
3.8
Salary & Benefits
3.8
Career Opportunities
3.9
Source